Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL)

Hematol Oncol. 2019 Oct;37(4):505-507. doi: 10.1002/hon.2638. Epub 2019 Jun 20.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Aged, 80 and over
  • Decitabine / administration & dosage*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell* / metabolism
  • Leukemia, Lymphocytic, Chronic, B-Cell* / pathology
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative* / diagnosis
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative* / drug therapy
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative* / metabolism
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative* / pathology
  • Male
  • Neoplasms, Second Primary* / diagnosis
  • Neoplasms, Second Primary* / drug therapy
  • Neoplasms, Second Primary* / metabolism
  • Neoplasms, Second Primary* / pathology

Substances

  • Decitabine